- Home
- ASMB vs JVSA Comparison
ASMB vs JVSA Comparison
Compare ASMB & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- JVSA
- Stock Information
- Founded
- ASMB 2005
- JVSA 2021
- Country
- ASMB United States
- JVSA Hong Kong
- Employees
- ASMB N/A
- JVSA N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- JVSA
- Sector
- ASMB Health Care
- JVSA
- Exchange
- ASMB Nasdaq
- JVSA NYSE
- Market Cap
- ASMB 130.2M
- JVSA 83.2M
- IPO Year
- ASMB 2010
- JVSA 2024
- Fundamental
- Price
- ASMB $18.14
- JVSA N/A
- Analyst Decision
- ASMB Strong Buy
- JVSA
- Analyst Count
- ASMB 3
- JVSA 0
- Target Price
- ASMB $33.00
- JVSA N/A
- AVG Volume (30 Days)
- ASMB 41.3K
- JVSA 96.6K
- Earning Date
- ASMB 08-07-2025
- JVSA 01-01-0001
- Dividend Yield
- ASMB N/A
- JVSA N/A
- EPS Growth
- ASMB N/A
- JVSA 719.53
- EPS
- ASMB N/A
- JVSA 0.27
- Revenue
- ASMB $32,154,000.00
- JVSA N/A
- Revenue This Year
- ASMB $0.04
- JVSA N/A
- Revenue Next Year
- ASMB N/A
- JVSA N/A
- P/E Ratio
- ASMB N/A
- JVSA $13.40
- Revenue Growth
- ASMB 148.33
- JVSA N/A
- 52 Week Low
- ASMB $7.75
- JVSA $3.12
- 52 Week High
- ASMB $19.93
- JVSA $19.28
- Technical
- Relative Strength Index (RSI)
- ASMB 68.18
- JVSA N/A
- Support Level
- ASMB $17.45
- JVSA N/A
- Resistance Level
- ASMB $18.92
- JVSA N/A
- Average True Range (ATR)
- ASMB 0.87
- JVSA 0.00
- MACD
- ASMB -0.05
- JVSA 0.00
- Stochastic Oscillator
- ASMB 74.68
- JVSA 0.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About JVSA JVSPAC ACQUISITION CORP
JVSPAC Acquisition Corp is blank check company.